CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-11 | Smith Cynthia Director | Option exercise · Restricted stock units | −2,302 | 4,604 | ||
| 2023-08-09 | Foster-Cheek Kaye I Director | Option exercise | +25,000 | $18.09 | $452K | 36,524 |
| 2023-08-09 | Foster-Cheek Kaye I Director | Sale | −25,000 | $25.96 | $649K | 11,524 |
| 2023-08-09 | Foster-Cheek Kaye I Director | Option exercise · Stock options (right to buy) | −25,000 | 4,307 | ||
| 2023-08-08 | Goff Brian Chief Executive Officer | Option exercise 10b5-1 | +22,691 | 36,770 | ||
| 2023-08-08 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −10,178 | $25.48 | $259K | 26,592 |
| 2023-08-08 | Goff Brian Chief Executive Officer | Option exercise · Restricted stock units 10b5-1 | −22,691 | 45,382 | ||
| 2023-08-07 | Washburn Theodore James Jr. Principal Accounting Officer | Sale | −2,918 | $25.39 | $74K | 2,741 |
| 2023-08-01 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise 10b5-1 | +4,150 | 6,891 | ||
| 2023-08-01 | Washburn Theodore James Jr. Principal Accounting Officer | Sale 10b5-1 | −1,232 | $26.26 | $32K | 5,659 |
| 2023-08-01 | Washburn Theodore James Jr. Principal Accounting Officer | Option exercise · Restricted stock units 10b5-1 | −4,150 | 0 | ||
| 2023-07-01 | Gheuens Sarah Chief Medical Officer | Grant or award · Restricted stock units | +25,124 | 25,124 | ||
| 2023-06-30 | Burns James William Chief Legal Officer | Sale 10b5-1 | −1,707 | $28.36 | $48K | 30,285 |
| 2023-06-30 | FOUSE JACQUALYN A Director | Sale 10b5-1 | −10,718 | $28.36 | $304K | 106,966 |
| 2023-06-30 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,707 | $28.36 | $48K | 24,159 |
| 2023-06-30 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −11,449 | $28.36 | $325K | 14,079 |
| 2023-06-30 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −1,597 | $28.36 | $45K | 3,783 |
| 2023-06-30 | Milanova Tsveta Chief Commercial Officer | Sale 10b5-1 | −1,618 | $28.36 | $46K | 3,831 |
| 2023-06-28 | Burns James William Chief Legal Officer | Option exercise 10b5-1 | +5,750 | 31,992 | ||
| 2023-06-28 | Burns James William Chief Legal Officer | Option exercise · Performance share units 10b5-1 | −5,750 | 5,750 |
Page 27 of 48 · 941 trades